Fleseriu M, Buchfelder M, Cetas JS, Fazeli PK, Mallea-Gil SM, Gurnell M, McCormack A, Pineyro MM, Syro LV, Tritos NA, Marcus HJ (2020) Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective. Pituitary 23(4):327–337. https://doi.org/10.1007/s11102-020-01059-7

Article  PubMed  PubMed Central  Google Scholar 

Kaiser UB, Mirmira RG, Stewart PM (2020) Our Response to COVID-19 as Endocrinologists and Diabetologists. J Clin Endocrinol Metab. 1;105(5):dgaa148. https://doi.org/10.1210/clinem/dgaa148

Frara S, Loli P, Allora A, Santini C, di Filippo L, Mortini P, Fleseriu M, Giustina A (2022) COVID-19 and hypopituitarism. Rev Endocr Metab Disord 23(2):215–231. https://doi.org/10.1007/s11154-021-09672-y

Article  PubMed  Google Scholar 

Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A (2021) COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine 72(2):301–316. https://doi.org/10.1007/s12020-021-02734-w

Article  PubMed  PubMed Central  Google Scholar 

Newell-Price J, Nieman LK, Reincke M, Tabarin A, Endocrinology in the time, OF COVID-19 (2020) Management of Cushing’s syndrome. Eur J Endocrinol 183(1):G1–G7. https://doi.org/10.1530/EJE-20-0352

Article  PubMed  PubMed Central  Google Scholar 

Giustina A, Legg E, Cesana BM, Frara S, Mortini P, Fleseriu M (2021) Results from ACROCOVID: an international survey on the care of acromegaly during the COVID-19 era. Endocrine. 71(2):273–280. https://doi.org/10.1007/s12020-020-02565-1 Erratum in: Endocrine. 72(2):596. doi: 10.1007/s12020-021-02720-2.7 (2021)

Puig-Domingo M, Marazuela M, Giustina A (2020) COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 68(1):2–5. https://doi.org/10.1007/s12020-020-02294-5

Article  PubMed  PubMed Central  Google Scholar 

Fleseriu M, Dekkers OM, Karavitaki N (2020) Endocrinology in the time of COVID-19: management of pituitary tumours. Eur J Endocrinol 183(1):G17–G23. https://doi.org/10.1530/EJE-20-0473

Article  PubMed  PubMed Central  Google Scholar 

Marazuela M, Giustina A, Puig-Domingo M (2020) Endocrine and metabolic aspects of the COVID-19 pandemic. Rev Endocr Metab Disord. 21(4):495–507. https://doi.org/10.1007/s11154-020-09569-2. Erratum in: Rev Endocr Metab Disord. 22(1):145. doi: 10.1007/s11154-020-09620-2 (2021)

di Filippo L, Frara S, Doga M, Giustina A (2022) The osteo-metabolic phenotype of COVID-19: an update. Endocrine 78(2):247–254. https://doi.org/10.1007/s12020-022-03135-3

Article  PubMed  PubMed Central  Google Scholar 

World Health Organization (2024) COVID-19 epidemiological update – 19 January 2024. https://www.who.int/publications/m/item/covid-19-epidemiological-update---19-january-2024 Accessed 30 Jan 2024

Oliver SE, Gargano JW, Marin M, Wallace M, Curran KG, Chamberland M, McClung N, Campos-Outcalt D, Morgan RL, Mbaeyi S, Romero JR, Talbot HK, Lee GM, Bell BP, Dooling K (2020) The Advisory Committee on Immunization practices’ interim recommendation for Use of Pfizer-BioNTech COVID-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep 18(50):1922–1924. https://doi.org/10.15585/mmwr.mm6950e2

Article  Google Scholar 

Katznelson L, Gadelha M (2021) Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement. Pituitary 24(2):143–145. https://doi.org/10.1007/s11102-021-01130-x

Article  PubMed  PubMed Central  Google Scholar 

Verrienti M, Marino Picciola V, Ambrosio MR, Zatelli MC (2024) Pituitary and COVID-19 vaccination: a systematic review. Pituit doi. https://doi.org/10.1007/s11102-024-01402-2

Article  Google Scholar 

National Institute for Health and Care Excellence (2021) COVID-19 rapid guideline: managing COVID-19. https://www.nice.org.uk/guidance/ng191 Accessed 10 Jul 2021

Instituto Brasileiro de Geografia e Estatística (2024) Censo 2022 – Panorama. https://censo2022.ibge.gov.br/panorama/?utm_source=ibge&utm_medium=home&utm_campaign=portal Accessed 03 Feb 2024

Ministério da Saúde (2024) Painel Coronavírus. https://covid.saude.gov.br/ Accessed 03 Feb 2024

Graf A, Marcus HJ, Baldeweg SE (2021) The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study. Pituitary 24(2):262–268. https://doi.org/10.1007/s11102-020-01106-3

Article  PubMed  Google Scholar 

Mascarenhas-Nakano MG, Correa-Silva BR, Fracacio S, Brock SMRW, Dias PF, Binda R, Santos-Neto ESS, Portari PF, Sanudo LHC, Abucham A (2024) The risk of COVID-19 in Cushing’s disease is independently related to disease activity (hypercortisolism) and obesity. Arch Endocrinol Metab 68:e220313. https://doi.org/10.20945/2359-4292-2022-0313

Article  PubMed Central  Google Scholar 

Chan JL, Gregory KD, Smithson SS, Naqvi M, Mamelak AN (2020) Pituitary apoplexy associated with acute COVID-19 infection and pregnancy. Pituitary 23(6):716–720. https://doi.org/10.1007/s11102-020-01080-w

Article  PubMed  PubMed Central  Google Scholar 

Ghosh R, Roy D, Roy D, Mandal A, Dutta A, Naga D, Benito-León J (2021) A rare case of SARS-CoV-2 infection Associated with Pituitary Apoplexy without comorbidities. J Endocr Soc 5(3):bvaa203. https://doi.org/10.1210/jendso/bvaa203

Article  PubMed  PubMed Central  Google Scholar 

Solorio-Pineda S, Almendárez-Sánchez CA, Tafur-Grandett AA, Ramos-Martínez GA, Huato-Reyes R, Ruiz-Flores MI, Sosa-Najera A (2020) Pituitary macroadenoma apoplexy in a severe acute respiratory syndrome-coronavirus-2-positive testing: causal or casual? Surg Neurol Int 11:304. https://doi.org/10.25259/SNI_305_2020

Article  PubMed  PubMed Central  Google Scholar 

Santos CDSE, Filho LMDCL, Santos CAT, Neill JS, Vale HF, Kurnutala LN (2020) Pituitary tumor resection in a patient with SARS-CoV-2 (COVID-19) infection. A case report and suggested airway management guidelines. Braz J Anesthesiol 70(2):165–170. https://doi.org/10.1016/j.bjane.2020.05.003

Article  PubMed  PubMed Central  Google Scholar 

Bordes SJ, Phang-Lyn S, Najera E, Borghei-Razavi H, Adada B (2021) Pituitary Apoplexy attributed to COVID-19 infection in the absence of an underlying Macroadenoma or Other Identifiable cause. Cureus 13(2):e13315. https://doi.org/10.7759/cureus.13315

Article  PubMed  PubMed Central  Google Scholar 

LaRoy M, McGuire M (2021) Pituitary apoplexy in the setting of COVID-19 infection. Am J Emerg Med 47:329e1–329e2. https://doi.org/10.1016/j.ajem.2021.02.045

Article  Google Scholar 

Zhang JJ, Dong X, Liu GH, Gao YD (2023) Risk and protective factors for COVID-19 morbidity, severity, and Mortality. Clin Rev Allergy Immunol 64(1):90–107. https://doi.org/10.1007/s12016-022-08921-5

Article  PubMed  Google Scholar 

Al Dossary R, Alnimr A, Aljindan R, Alkharsah KR, Al-Qurayn AK, Eltreifi O, Alkuwaiti FA, Almashouf AB, Alsahlawi AM, Alshammari A, Hudhaiah D, Alshahrani MS, Bukhari H (2021) Predictors of illness severity in COVID-19 cases in Saudi Arabia. Infect Drug Resist 14:4097–4105. https://doi.org/10.2147/IDR.S333300

Article  PubMed  PubMed Central  Google Scholar 

Pijls BG, Jolani S, Atherley A, Derckx RT, Dijkstra JIR, Franssen GHL, Hendriks S, Richters A, Venemans-Jellema A, Zalpuri S, Zeegers MP (2021) Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open 11(1):e044640. https://doi.org/10.1136/bmjopen-2020-044640

Article  PubMed  Google Scholar 

Chen Y, Klein SL, Garibaldi BT, Li H, Wu C, Osevala NM, Li T, Margolick JB, Pawelec G, Leng SX (2021) Aging in COVID-19: vulnerability, immunity and intervention. Ageing Res Rev 65:101205. https://doi.org/10.1016/j.arr.2020.101205

Article  PubMed  Google Scholar 

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y (2020) Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 180(7):934–943. doi: 10.1001/jamainternmed.2020.0994 Erratum in: JAMA Intern Med. 180(7):1031. https://doi.org/10.1001/jamainternmed.2020.1429 (2020)

Masana L, Correig E, Ibarretxe D, Anoro E, Arroyo JA, Jericó C, Guerrero C, Miret M, Näf S, Pardo A, Perea V, Pérez-Bernalte R, Plana N, Ramírez-Montesinos R, Royuela M, Soler C, Urquizu-Padilla M, Zamora A, Pedro-Botet J (2021) STACOV-XULA research group. Low HDL and high triglycerides predict COVID-19 severity. Sci Rep 11(1):7217. https://doi.org/10.1038/s41598-021-86747-5

Article  PubMed  PubMed Central  Google Scholar 

Dutcher EG, Epel ES, Mason AE, Hecht FM, Robinson JE, Drury SS, Prather AA (2024) COVID-19 Vaccine Side effects and Long-Term neutralizing antibody response: a prospective cohort study. Ann Intern Med 177(7):892–900. https://doi.org/10.7326/M23-2956

Article  PubMed  Google Scholar 

Xie Y, Lv S, Luo S, Chen Y, Du M, Xu Y, Yang D (2024) The correlation between corona virus disease 2019 and Alopecia Areata: a literature review. Front Immunol 15:1347311. https://doi.org/10.3389/fimmu.2024.1347311

Article  PubMed  PubMed Central  Google Scholar 

Passarelli-Araujo H, Pott-Junior H, Susuki AM, Olak AS, Pescim RR, Tomimatsu MFAI, Volce CJ, Neves MAZ, Silva FF, Narciso SG, Aschner M, Paoliello MMB, Urbano MR (2022) The impact of COVID-19 vaccination on case fatality rates in a city in Southern Brazil. Am J Infect Control 50(5):491–496. https://doi.org/10.1016/j.ajic.2022.02.015